Recognizing that equity, diversity, and inclusion in federally funded health research is necessary to enhance scientific excellence, and ensure equitable outcomes for patients in the United States.
About This Bill
Committee
Latest Action · July 16, 2026
Referred to the House Committee on Energy and Commerce.
This resolution expresses the House of Representatives' support for diversity and inclusion in federally funded health research and opposes proposed changes to how federal research grants are managed. The resolution specifically criticizes a proposed rule from the Office of Management and Budget that would give political appointees greater control over federal research grants, reduce reliance on scientific peer review, restrict international research collaborations, and prohibit funding for diversity and inclusion research. The resolution argues that excluding women and people of color from medical research has led to inferior health outcomes and diagnostic tools that work less effectively for these populations, and that diversity in research is essential for scientific excellence and addressing health disparities across the country. The House recognizes that the current peer-review system managed by career scientists and experts has made the United States a leader in health innovation and calls on the administration to preserve this science-based approach rather than allow political considerations to drive research funding decisions.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.